Cart
sales@molnova.com
9-Cyclopentyladenine
CAS No. 715-91-3
9-Cyclopentyladenine( —— )
Catalog No. M34489 CAS No. 715-91-3
9-Cyclopentyladenine (NSC-19486) is an adenylate cyclase inhibitor that blocks cellular morphological differentiation and phosphorylation of specific signaling molecules.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 409 | In Stock |
|
| 10MG | 604 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1265 | In Stock |
|
| 100MG | 1702 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3422 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name9-Cyclopentyladenine
-
NoteResearch use only, not for human use.
-
Brief Description9-Cyclopentyladenine (NSC-19486) is an adenylate cyclase inhibitor that blocks cellular morphological differentiation and phosphorylation of specific signaling molecules.
-
Description9-Cyclopentyladenine (NSC-19486) is an adenylate cyclase inhibitor that blocks cellular morphological differentiation and phosphorylation of specific signaling molecules.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number715-91-3
-
Formula Weight203.24
-
Molecular FormulaC10H13N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=C2C(N(C=N2)C3CCCC3)=NC=N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
VU10010
VU 10010 is allosteric potentiator of M4 acetylcholine receptors.
-
(±)-Acetylcarnitine ...
(±)-Acetylcarnitine chloride (Acetyl dl-carnitine chloride) is a weak cholinergic agonist with neuroprotective properties and can be used in studies of neuritis.
-
Lobelanidine
Lobelanidine (8,10-Diphenyllobelidiol), which can be extracted from the above-ground parts of Lobelia chinensis Lour and Lobelia tupa, is an analogue of lobeline and shows a moderate affinity for nAChR.
